A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects.

Trial Profile

A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jun 2012

At a glance

  • Drugs BMS 986094 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 03 Nov 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 31 Mar 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
    • 01 Sep 2010 The actual patient number (n=42) was reported in an Inhibitex media release. Inhibitex also plans to present detailed results at an upcoming scientific meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top